TERGYNAN, vaginal tablet 10 tablets
Brand page: Tergynan (ternidazole + neomycin + nystatin + prednisolone) — all forms and strengths in France
Active ingredients: Metronidazole, Nystatin, Neomycin sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet10 tabletsvaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TERGYNAN, comprimé vaginal
- Pharmaceutical form
- comprimé
- Route of administration
- vaginale
- Presentation description
- film(s) thermosoudé(s) papier kraft polyéthylène basse densité (PEBD) aluminium de 10 comprimé(s)
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Dec 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68802779CIP73415256CIP133400934152566Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTRONIDAZOLEcomprimé | 500 mg · un comprimé | SA |
| NYSTATINEcomprimé | 100 000 UI · un comprimé | SA |
| SULFATE DE NÉOMYCINEcomprimé | 65 000 UI · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.